EP0806965A4 - Cd44 expression in smooth muscle cells - Google Patents

Cd44 expression in smooth muscle cells

Info

Publication number
EP0806965A4
EP0806965A4 EP95910105A EP95910105A EP0806965A4 EP 0806965 A4 EP0806965 A4 EP 0806965A4 EP 95910105 A EP95910105 A EP 95910105A EP 95910105 A EP95910105 A EP 95910105A EP 0806965 A4 EP0806965 A4 EP 0806965A4
Authority
EP
European Patent Office
Prior art keywords
expression
smooth muscle
muscle cells
cells
smooth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95910105A
Other languages
German (de)
French (fr)
Other versions
EP0806965A1 (en
Inventor
Qi He
Edgar Haber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of EP0806965A1 publication Critical patent/EP0806965A1/en
Publication of EP0806965A4 publication Critical patent/EP0806965A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70585—CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP95910105A 1994-01-18 1995-01-18 Cd44 expression in smooth muscle cells Withdrawn EP0806965A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18315694A 1994-01-18 1994-01-18
US183156 1994-01-18
PCT/US1995/000740 WO1995019183A1 (en) 1994-01-18 1995-01-18 Cd44 expression in smooth muscle cells

Publications (2)

Publication Number Publication Date
EP0806965A1 EP0806965A1 (en) 1997-11-19
EP0806965A4 true EP0806965A4 (en) 2000-06-07

Family

ID=22671682

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95910105A Withdrawn EP0806965A4 (en) 1994-01-18 1995-01-18 Cd44 expression in smooth muscle cells

Country Status (5)

Country Link
EP (1) EP0806965A4 (en)
JP (1) JPH09508265A (en)
AU (1) AU689226B2 (en)
CA (1) CA2179391A1 (en)
WO (1) WO1995019183A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
WO1998006839A1 (en) * 1996-07-15 1998-02-19 Human Genome Sciences, Inc. Cd44-like protein
CN103648517B (en) * 2011-03-24 2016-04-20 纽瑞姆制药（1991）有限公司 Neuroprotective peptide
CN112673983A (en) * 2020-12-21 2021-04-20 重庆工商大学 Preparation method and product of pet chew based on glycosylation modified soybean protein isolate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
B. YANG ET AL.: "Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.", EMBO J., vol. 13, no. 2, 15 January 1994 (1994-01-15), pages 286 - 296, XP002134781 *
BRUHN H.D. ET AL.: "Untersuchung zur Pathogenese der Arteriosklerose.", MEDIZINISCHE WELT, vol. 33, no. 10, March 1982 (1982-03-01), pages 347 - 351, XP000882890 *
LANGE R. ET AL.: "Southwestern Internal Medicine Conference : Restenosis, the Achilles heel of coronary angioplasty.", AM. J. MED. SCI., vol. 306, no. 4, October 1993 (1993-10-01), pages 265 - 275, XP000881860 *
PICKER ET AL.: "Monoclonal antibodies to human lymphocytes homing receptors define a novel class of adhesion molecules on diverses cell types", J. CELL. BIOL., vol. 109, no. 2, 1989, pages 927 - 938, XP000881846 *
See also references of WO9519183A1 *

Also Published As

Publication number Publication date
JPH09508265A (en) 1997-08-26
AU1832695A (en) 1995-08-01
EP0806965A1 (en) 1997-11-19
WO1995019183A1 (en) 1995-07-20
CA2179391A1 (en) 1995-07-20
AU689226B2 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
GB2307045B (en) Improvements in or relating to super-conducting nagnets
GB2293372B (en) Improvements in refining
EP0814810A4 (en) Adenosine as a positive inotrop in the compromised heart
GB9424441D0 (en) Batteries
GB9520488D0 (en) Improvements in desks
GB9418475D0 (en) Battery
EP0806965A4 (en) Cd44 expression in smooth muscle cells
PL339259A1 (en) Gonadothropin expression in dictostelium
GB9502317D0 (en) Improvements in or relating to turbines
GB9605515D0 (en) Improvements in or relating to cell stimulation
GB9504832D0 (en) Improvements in lockig means
GB9404135D0 (en) Improvement in or relating to hinges
EP0762914A4 (en) Improvements in racquets
GB9425050D0 (en) Cell line
GB2322794B (en) Improvements in or relating to storage units
GB9423140D0 (en) 2 in 1 battery
GB9519600D0 (en) Improvements in or relating to handpumps
GB9422523D0 (en) Human cell lines
HU9400235V0 (en) Drink-paccked in boxes-pouring
GB9411007D0 (en) Improvements in flylines
ZA956473B (en) Shampoo in solid form
GB9413796D0 (en) Improvements in or relating to turbines
GB9402077D0 (en) Improvements in or relating to turbines
GB9404099D0 (en) Improvements in or relating to turbines
GB9414866D0 (en) Electrochemical methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960719

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20000427

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020801